Viewing Study NCT07310420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-07-03 @ 11:04 AM
Study NCT ID: NCT07310420
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-11
First Post: 2025-12-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
Sponsor: TerSera Therapeutics LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian Suppression View
None ZOLADEX View
None HR+ View
None HER2- View
None Breast Cancer View
None Goserelin Implant View